Excella GmbH & Co. KG GlaxoSmithKline Pharmaceuticals S.A.
PolandAll drugs from this manufacturer
-
The medicine is used to treat certain blood diseases and cancers, such as acute myeloid leukemia and acute lymphoblastic leukemia.
Dosage form: tablets
Active substance Dosage tioguanine 40 mg ATC: L01BB03
-
The medicine is intended for the treatment of certain types of blood and lymphatic cancers, such as Hodgkin's disease, non-Hodgkin's lymphomas, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
Dosage form: tablets, film-coated
Active substance Dosage chlorambucil 2 mg ATC: L01AA02
-
The medicine is used to treat certain blood disorders, such as chronic myeloid leukemia, polycythemia vera, thrombocytosis, and myelofibrosis. It is also used as part of preparation for a hematopoietic stem cell or bone marrow transplant.
Dosage form: tablets, film-coated
Active substance Dosage busulfan 2 mg ATC: L01AB01